piperacillin has been researched along with Haemophilus influenzae Meningitis Type B in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukasawa, C; Hoshino, T; Ishiwada, N; Kutsuna, S; Sato, H; Sawada, K | 1 |
Kitazato, M; Minami, S; Mitsuyama, J; Mizunaga, S; Morikawa, Y; Watanabe, Y | 1 |
2 other study(ies) available for piperacillin and Haemophilus influenzae Meningitis Type B
Article | Year |
---|---|
[Concentration of tazobactam/piperacillin in the cerebrospinal fluid of patients with Haemophilus influenzae type B meningitis].
Topics: Anti-Bacterial Agents; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Meningitis, Haemophilus; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome | 2013 |
In vitro activities of piperacillin against beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.
Topics: Ampicillin Resistance; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Ceftriaxone; Cephalosporins; Haemophilus influenzae; Hexosyltransferases; Humans; Kinetics; Meningitis, Haemophilus; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Piperacillin | 2004 |